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Background: Immunoglobulin G4-related kidney disease characterized by immunoglobulin G4-positive plasma cell-rich
tubulointerstitial nephritis has distinctive serological and radiological findings. Renal prognosis is good because of a
good response to glucocorticoids. Here we report a case of successful treatment of highly advanced
immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure.
Case Presentation: A 59-year-old Japanese man was referred to our hospital because of uremia with a creatinine
level of 12.36 mg/dL. Urinalysis revealed mild proteinuria and hyperβ2microglobulinuria, and blood tests showed
hyperglobulinemia with an IgG level of 3243 mg/dL and an IgG4 level of 621 mg/dL. Non-contrast computed
tomography revealed renal mass-like regions. Based on the findings, immunoglobulin G4-related kidney disease was
suspected, however, further radiological examination showed unexpected results. Ga-67 scintigraphy showed no kidney
uptake. T2-weighted magnetic resonance imaging revealed high-intensity signals which corresponded to mass-like
regions and multiple patchy low-intensity signals in kidney cortex. Finally, the patient was diagnosed with
immunoglobulin G4-related kidney disease by renal pathology of severe immunoglobulin G4-positive plasma cell-
rich tubulointerstitial nephritis and characteristic fibrosis. He received 50 mg oral prednisolone, which was tapered with
a subsequent decrease of serum creatinine and IgG4 levels. One year after initiation of treatment, he achieved
normalization of serum IgG4 level and proteinuria, and remained off dialysis with a creatinine level of 3.50 mg/dL. After
treatment with steroids, repeat imaging suggested bilateral severe focal atrophy. However, mass-like regions did not
show atrophic change although renal atrophy was evident in patchy low-intensity lesions on T2-weighted magnetic
resonance imaging. These findings suggest that multiple patchy low-intensity signals and high-intensity mass-like regions
were mildly atrophic lesions of immunoglobulin G4-related kidney disease due to severe fibrosis and normal
parts of kidney, respectively.
Conclusions: In immunoglobulin G4-related kidney disease with severe kidney failure, radiological findings should be
carefully examined. In addition, renal prognosis may be good despite highly advanced tubulointerstitial nephritis and
fibrosis.
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IgG4-related disease (IgG4-RD) is a recently recognized
emerging clinicopathological entity characterized by sev-
eral features: tumefactive lesions, a dense lymphoplas-
macytic infiltrate rich in IgG4-positive plasma cells with
fibrosis, and usually an elevated serum IgG4 concentra-
tion [1]. This fibro-inflammatory condition occurs in
multiple organs including the kidneys. Clinical symp-
toms vary depending on the affected organ, but they are
relatively mild, and organ swelling may be the only diag-
nostic clue in many patients. IgG4-RD is diagnosed by a
combination of clinical serological and radiological find-
ings along with pathological features [2]. IgG4-related
kidney disease (IgG4-RKD) is a comprehensive term for
renal lesions associated with IgG4-RD [3]. Here, we
describe a case of highly advanced IgG4-RKD presenting
mass-like regions with end-stage kidney failure.
Case presentation
A 59-year-old man was admitted to our hospital because
of severe kidney failure. He complained only of general
fatigue. He had no medical history and was on no medi-
cation. Urinalysis revealed no hematuria, mild proteinuria
(Total protein 0.56 g/day) and hyperβ2microglobulinuria
although he had no abnormal urinary findings until
6 months prior to admission. Blood tests showed anemia
with a hemoglobin level of 10.5 g/dL, kidney failure with a
creatinine level of 12.36 mg/dL (normal level, 0.5–1.1 mg/
dL), hypocomplementemia with a C3 level of 51 mg/dL
and C4 level of 3 mg/dL, an elevated serum anti-double-
stranded DNA antibody level of 44 IU/mL, and hyperglo-
bulinemia with an IgG level of 3243 mg/dL (normal level,
870–1700 mg/dL) and an IgG4 level of 621 mg/dL (nor-
mal level, 4.8–105 mg/dL). Echography and computed
tomography without contrast revealed mass-like regions
(Fig. 1). Based on these findings, tumefactive lesion of
IgG4-RKD was suspected, but no other intercurrent IgG4-
related lesion such as pancreatitis was noted. Furthera b
Fig. 1 Findings of Echography and computed tomography before treatme
mass-like regions (arrow head) by computed tomographyimaging examinations were performed to detect diagnos-
tic findings associated with IgG4-RKD. Ga-67 scintigraphy
showed no kidney uptake. T2-weighted magnetic reson-
ance (MR) imaging revealed multiple patchy low-intensity
signals and some high-intensity signals in kidney cortex.
High-intensity signals corresponded to mass-like regions
(Fig. 2). These findings were not typical for IgG4-RKD.
Finally, he was diagnosed with IgG4-RKD by renal path-
ology with massive tubulointerstitial nephritis (TIN), char-
acteristic fibrosis (bird’s eye pattern), and IgG4-positive
plasma cell infiltrate (Fig. 3). There was no deposition of
globulin or complement in the glomeruli and no evidence
of glomerular sclerosis. He received 50 mg oral prednisol-
one. With a subsequent decrease of serum creatinine and
IgG4 levels, prednisolone was decreased by 2.5 to 10 mg
every two to four weeks after induction therapy for
6 weeks. Finally he received maintenance therapy with
5 mg of prednisolone 6 months after initiation of treat-
ment. One year after initiation of treatment, he achieved
normalization of serum IgG4 level and proteinuria, and
remained off dialysis with a creatinine level of 3.50 mg/dL,
although severe focal atrophy developed in bilateral kidney
(Fig. 4). However, mass-like regions did not show atrophic
change although renal atrophy was evident in patchy
low-intensity lesions on T2-weighted magnetic reson-
ance imaging.
Discussion and conclusions
IgG4-RD predominantly affects middle-aged and older
men. Most patients with IgG4-RKD have IgG4-related
extrarenal lesions such as in the salivary glands, lacrimal
glands, lymph nodes, or pancreas. Clinical symptoms
differ depending on the involved organs [4]. The most
dominant features of IgG4-RKD are IgG4-positive
plasma cell-rich TIN and characteristic fibrosis, which
are sometimes concurrent with glomerular lesions [3, 5].
Abnormal urinary findings and clinical symptoms spe-
cific to IgG4-related TIN are mild, although edemant. (a) Multiple high echoic lesions (arrows) by Echography and (b)
a b
Fig. 2 Findings of Ga-67 scintigraphy and MR imaging. (a) No uptake to kidney by Ga-67 scintigraphy and (b) low-intensity signals (arrow head)
and high-intensity signals (arrow) by T2-weighted MR imaging
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a diagnostic clue. Thus, IgG4-RKD is often diagnosed
during examination of a systemic IgG4-related disease.
However, our patient had no extrarenal lesions and no
evidence of physical findings, so the final diagnostic clue
was uremia with general fatigue resulting from severe
kidney failure. Urinary findings showed only mild pro-
teinuria and hyperβ2microglobulinuria. Renal pathology
revealed severe TIN with fibrosis specific to IgG4-RKD
and minor glomerular abnormalities. These data suggest
that the patient’s end stage kidney failure resulted from
IgG4-related TIN.
A definitive diagnosis of IgG4-RKD is achieved mainly
by laboratory data and renal pathology, but characteristic
radiological findings are also useful: low-density lesions
by enhanced computed tomography, increased uptake by
Ga-67 scintigraphy and FDG-PET, and low- and high-
intensity lesions on T2-weighted and diffusion-weighted
MR imaging [6, 7]. These findings indicate a hypo-
vascular free water-eliminated lesion with dense cellular
infiltration and fibrosis of IgG4-TIN. Our patient
showed atypical radiological findings for IgG4-RKD:
multiple renal cortex mass-like regions which show
high-intensity signals on T2-weighted MR imaging andTubulointerstitial nephritis and minor 
glomerular abnormality
Bird’s eye pattern fi
a b
Fig. 3 Pathological findings. (a) Tubulointerstitial nephritis and minor glom
shown by PAM stain and (c) IgG4 positive cell:40/HPF shown by Immunostno uptake to kidney by Ga-67 scintigraphy. After treat-
ment, mass-like regions did not show atrophic change
although renal atrophy was evident in low-intensity
lesions on T2-weighted MR imaging. Kidney parenchy-
mal lesions were categorized as follows: patchy or
wedged-shaped lesions, diffuse lesions or peripheral cor-
tical nodules [7]. Patchy lesions show convex shape
when TIN is severe. Patients with diffuse lesions often
show swollen kidney with decreased kidney function.
These findings suggest that our patient before treatment
showed end stage kidney disease with mild focal kidney
atrophy due to highly advanced multiple lesions of
IgG4-TIN. Therefore, normal parts of kidney looked
“mass-like regions” in this case although IgG4-RKD pre-
sents tumefactive lesions in some cases. In an IgG4-RKD
patient with advanced kidney failure, the imaging tests
should be carefully examined.
The optimal treatment for IgG4-RD has not been
established, but most patients respond to glucocorticoid
therapy [1]. In a study of 43 Japanese patients with
IgG4-RKD, glucocorticoid treatment led a rapid im-
provement of kidney function and serological abnormal-
ities 1 month after the start of therapy, and maintenance
therapy with low-dose glucocorticoids suppressedbrosis IgG4 positive cell:40/HPF
c
erular abnormality shown by PAS stain, (b) Bird’s eye pattern fibrosis
aining for IgG4
Fig. 4 Findings of computed tomography after treatment. Focal
atrophy of kidneys. Mass-like regions before treatment did not show
atrophic change by computed tomography
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one patient with advanced kidney damage due to IgG4-
TIN required maintenance hemodialysis. Renal atrophy
after treatment frequently occurs, especially in patients
with advanced kidney damage. Atrophic changes prob-
ably resulted from advanced fibrosis and decreased infil-
tration of inflammatory cell in the renal interstitium.
These findings suggest that early diagnosis and treat-
ment of IgG4-TIN are essential. Our patient had end-
stage kidney disease with an estimated glomerular filtra-
tion rate (eGFR) < 10 mL/min at the time of diagnosis
and finally had severe focal renal atrophy. However, he
did not require maintenance dialysis, as his eGFR was
about 20 mL/min while undergoing maintenance ther-
apy. The clinical cause of his favorable outcome may be
that he had no complications such as hypertension or
diabetes mellitus, and did not take a renal toxic reagent
such as contrast. The pathological features of IgG4-
TIN may also contribute to the outcome. Nephron
function in the non-fibrotic region is probably main-
tained in IgG4-related TIN because plasma cell-
infiltrative and fibrotic lesions show a well-defined re-
gional distribution. In this case, nephron probably
functions in “mass-like” regions. It may be also favor-
able that necrotizing angiitis and advanced tubulitis,
which may decrease kidney function, are rare in
IgG4-TIN in contrast to other types of TIN caused
by a drug or collagen disease [8]. Taken together,
IgG4-related TIN should be actively treated with glu-
cocorticoids even though kidney function greatly de-
creases at the time of diagnosis.IgG4-RKD is a recently recognized condition with
pathological feature. Renal prognosis is relatively good
because, in general, patients respond rapidly to glucocor-
ticoids. The clinical evidence for IgG4-RKD is still being
investigated. Our case adds evidence to the pathophysi-
ology of IgG4-RKD.
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